Last Updated: May 5, 2026
Ketamine Therapy for Insomnia: At-Home vs. In-Clinic Options
This article compares at-home ketamine therapy providers for adults experiencing sleep disturbance alongside anxiety, depression, or PTSD, covering published outcomes data, care models, administration methods, pricing, and safety protocols.
Key takeaways
- Mindbloom is the only at-home ketamine provider with published sleep outcomes data, based on a 2026 research preprint of 13,963 adults.8
- Participants demonstrated a 77 percent sleep response rate, with 67.4 percent meeting the response threshold by their second session.8
- Mindbloom clients showed approximately 29 percent greater average gains in sleep disturbance scores than published esketamine data in a non-head-to-head cross-study comparison.1
- Mindbloom is the only at-home provider offering subcutaneous ketamine administration, which provides higher bioavailability than sublingual-only options.
What Is At-Home Ketamine Therapy?
At-home ketamine therapy is a telehealth-based treatment model where a licensed provider evaluates, prescribes, and monitors medication that you take in your own home. Remote care convenience and a defined treatment framework are combined in this model. Patients can undergo therapy in a familiar, comfortable environment while maintaining medical oversight.
Every step of the care flow is designed to promote safety and support. "At-home" does not mean unsupervised, because medical screening and ongoing provider involvement distinguish the model from unmonitored use. A typical treatment journey includes several key stages:
- Medical screening: An initial online intake assesses your health history and current symptoms.
- Provider consult: A licensed specialist conducts a video evaluation to determine eligibility and prescribe treatment.
- Prescription delivery: A compounding pharmacy ships the medication directly to your residence.
- Guided session: You complete the treatment at home with a required peer treatment monitor present.
- Follow-up: Care teams and guides provide ongoing oversight and integration support.
How Does Ketamine Therapy Work?
Ketamine temporarily modulates glutamate signaling and adjusts NMDA receptor activity in the brain.4 As a result, neuroplasticity increases, strengthening the brain's ability to form and reorganize neural connections. Conventional antidepressants primarily target serotonin or norepinephrine pathways, making ketamine's mechanism distinctly different.
Increased neuroplasticity creates a window where entrenched thought patterns, emotional responses, and behavioral loops become more changeable. In Mindbloom's published data, 89 percent of clients reported symptom improvement for anxiety and depression, with many experiencing changes within the first few sessions. More durable and cumulative benefits typically develop over a series of sessions.
Integration practices help consolidate changes during the neuroplastic window. Examples of integration include:
- Journaling: Writing down insights immediately after a session.
- Reflection: Spending quiet time processing the experience.
- Coaching: Working with a guide to apply insights to daily life.
A substantial body of peer-reviewed research supports ketamine's efficacy across depression, anxiety disorders, PTSD, and related conditions.4 The neuroplasticity mechanism is also highly relevant to sleep disruption. Mood and anxiety patterns that ketamine helps reorganize are often the primary drivers of chronic sleep issues.
Ketamine has been FDA-approved as an anesthetic since 1970 and has been on the World Health Organization List of Essential Medicines since 1985.2Off-label prescribing for mental health conditions is a widespread, legally accepted medical practice.3 At-home ketamine therapy applies an established medicine within a modern telehealth delivery model.
Can Ketamine Therapy Help Insomnia?
Ketamine therapy can be relevant to insomnia when sleep disturbance is intertwined with anxiety, depression, or PTSD. Disrupted sleep is one of the most common symptoms of these mood conditions. Treating the underlying condition often improves sleep concurrently.8
Depression, anxiety, and PTSD frequently disrupt sleep onset and sleep maintenance. Rumination, hyperarousal, and a dysregulated stress response are common consequences of these conditions. When ketamine therapy reduces the severity of the underlying conditions, sleep can improve as a downstream effect. Rather than acting as a sedative, ketamine quiets the cognitive and emotional drivers that keep sleep inaccessible.
Mindbloom only treats clients with qualifying diagnoses of anxiety, depression, or PTSD. For individuals whose insomnia is intertwined with one of those conditions, ketamine therapy may improve sleep as part of broader symptom relief. Eligibility is always determined by a licensed physician during the medical evaluation.
Mindbloom's Published Sleep Outcomes
A 2026 research preprint evaluated sleep disturbance findings in Mindbloom clients receiving at-home ketamine therapy.8 The preprint analyzed a sample size of 13,963 adults. The individuals were treated for anxiety, depression, or PTSD and experienced comorbid sleep disturbances.
Across the patient population, sleep quality improved significantly. Both rapid relief and sustained benefits emerged from the data. Key data points include:
- Sleep response rate: 77% of clients met the threshold for clinically meaningful sleep improvement by session 6.
- Average improvement: Participants saw a 49% average reduction in sleep disturbance scores.
- Early response: 67.4% met the sleep response threshold by session 2, indicating rapid improvement.
- Complete resolution: 21% of clients experienced complete resolution of sleep disturbance.
- Comparison to esketamine: Clients showed about 29% greater average improvement in sleep disturbance than published esketamine (Spravato) data in a non-head-to-head cross-study comparison.1
Mindbloom is the only at-home ketamine provider with published sleep improvement data. Sleep response in the study was measured using PHQ-9 Item 3, a validated clinical instrument that tracks trouble falling or staying asleep, or sleeping too much. Results may vary, and the outcomes were observed in clients treated for comorbid anxiety, depression, or PTSD rather than standalone insomnia.
Mindbloom At-Home Ketamine Therapy Overview
Mindbloom is one of the largest providers of guided at-home ketamine therapy in the United States. To date, over 800,000 supervised sessions have been facilitated through the platform. Mindbloom delivers rigorous, evidence-based care designed to create conditions for meaningful change.
The Mindbloom care model provides a thorough support ecosystem beyond just the medication. Mindbloom offers programs of 6, 12, or 18 sessions. After you select a program, a licensed provider conducts a detailed medical evaluation to confirm your eligibility and personalize your care plan.
The program includes several core components:
- Provider consults: Licensed specialists conduct medical evaluations, confirm eligibility, and monitor progress.
- Ketamine treatments: Both sublingual tablets and subcutaneous injectables are available, making Mindbloom the only at-home provider offering subcutaneous administration.
- Guide coaching: You receive one-on-one sessions with a dedicated guide for preparation and integration.
- Unlimited guide messaging: You have ongoing access to a guide between your sessions.
- Group Integration Circles: Clients get unlimited access to peer-led integration sessions.
- Bloombox: A physical toolkit with all session essentials is shipped directly to you.
- Mindbloom App: The app provides comprehensive programs with custom soundscapes and integration resources.
Mindbloom has released two of the largest peer-reviewed, real-world outcomes studies of at-home ketamine therapy to date.5,6 The studies appear in the Journal of Affective Disorders, alongside research preprints on PTSD and sleep results. New-client pricing ranges from $165 to $215 per session depending on program length — well below the typical IV ketamine clinic range of $400 to $800 per session. All programs are HSA and FSA eligible.
Other At-Home Ketamine Providers
Two other at-home ketamine providers are commonly considered alongside Mindbloom: Joyous and Innerwell. Each offers a different approach to treatment cadence and medical support.
Joyous Overview
Joyous is an at-home ketamine provider that uses a very-low-dose daily dosing model. The approach may suit individuals looking for a daily microdosing-style routine with lower per-session intensity.
The Joyous care model involves taking daily low-dose oral ketamine. Support is primarily managed through app-based check-ins and provider oversight. The pricing model is a flat monthly subscription that includes the medication and digital check-ins.
Joyous's daily-dosing model is designed for clients who prefer a low-intensity, ongoing routine over discrete guided sessions. The flat subscription pricing makes the cost commitment predictable month-to-month.
Innerwell Overview
Innerwell is an at-home ketamine therapy provider offering sublingual ketamine through a telehealth care model. The service may suit individuals looking for standard sublingual treatments at home.
Innerwell's program includes psychiatric evaluations, sublingual medication, and access to a patient portal. Their pricing structure varies based on the level of medical support and the number of sessions selected.
Innerwell's tiered package model gives clients flexibility to scale clinical support up or down based on involvement preference, with a portal-based experience between sessions.
How At-Home Ketamine Providers Compare
The following comparison evaluates Mindbloom, Joyous, and Innerwell across five dimensions that matter most when choosing an at-home ketamine provider for sleep-related concerns. Direct comparisons across treatment modalities should be interpreted with caution due to differences in study design, patient populations, and outcome measures.
| Feature | Mindbloom | Joyous | Innerwell |
|---|---|---|---|
| Published sleep outcomes | Yes | No | No |
| Published peer-reviewed research | Yes | No | No |
| Administration methods | Sublingual & Subcutaneous | Sublingual only | Sublingual only |
| Care model components | Provider consults, 1:1 coaching, group circles | App-based check-ins | Provider consults, portal |
| Integration support | Protocol-driven 1:1 and group integration | Self-guided | Varies by plan |
| Pricing structure | Per-session (monthly installments) | Monthly subscription | Package-based |
| Subcutaneous option available | Yes | No | No |
Clinical Evidence and Published Research
Published research on a provider's own protocol can provide evidence about reported results and adverse events for that specific care model. Mindbloom has produced four published assets on its own protocol: two peer-reviewed real-world outcomes studies in the Journal of Affective Disorders (Hull et al., 2022; Mathai et al., 2024), a PTSD preprint, and a sleep outcomes preprint (n=13,963).5,6,8,9 In Mindbloom's peer-reviewed studies, 89 percent of clients reported symptom improvement for anxiety, and depression response rates ranged from 56 to 63 percent.5,6
Mindbloom's safety data shows side effects occur in approximately 4 to 5 percent of sessions, with serious adverse events in fewer than 0.1 percent.5 Mindbloom is the only at-home provider with published sleep data. Joyous and Innerwell have not published peer-reviewed efficacy data on their own protocols.
Care Model and Integration Support
A robust care ecosystem provides support beyond the medication itself. Mindbloom includes provider consults, one-on-one guide coaching, unlimited messaging, group integration circles, app-based programs, and a physical Bloombox. The clinically managed program emphasizes preparation and integration.
Joyous utilizes a check-in-only model driven by automated daily text messages and app interactions. Innerwell offers a prescription model with varying levels of medical support depending on the purchased package. Mindbloom's model is highly protocol-driven to support durable change.
Administration Methods and Options
Mindbloom is the only at-home provider offering both sublingual tablets and subcutaneous injectables. Subcutaneous administration uses a tiny insulin needle to deliver the medication. Compared to oral routes, this method offers higher bioavailability and a more consistent onset time.
Joyous and Innerwell exclusively offer oral tablet administration. Both oral and subcutaneous options are individualized choices based on medical fit, comfort, and preference. Your physician will help determine the best administration route for your needs.
Cost, Accessibility, and Convenience
Mindbloom's per-session pricing for new clients ranges from $165 in the 18-session program to $215 in the 6-session program, with the 6-session option billed as $430 per month over 3 months. Returning clients are eligible for pricing as low as $129 per session in the 18-session program. By comparison, traditional IV ketamine clinics typically charge between $400 and $800 per session.
Joyous charges a flat monthly subscription fee for daily microdosing. Innerwell charges based on specific session packages. Mindbloom's pricing includes the full program of coaching, integration, and tools, and all programs are HSA and FSA eligible.
Safety Protocols and Screening
Mindbloom requires a peer treatment monitor to be present during every session. Screening includes a comprehensive medical evaluation, contraindication assessment, and cardiovascular review.
Mindbloom's reported safety data reinforces the protocol, showing a discontinuation rate of just 0.4 percent.5 Joyous and Innerwell also utilize telehealth medical screening, though their in-session monitoring requirements differ. Mindbloom's strict peer treatment monitor requirement is intended to make immediate support available during sessions if needed.
Which Option Is Right for You?
Choosing the right provider depends on your specific symptoms, preferences, and need for medical support.
Mindbloom may be right for you if:
- You have a diagnosis of anxiety, depression, or PTSD and also experience sleep disturbance.
- You want a provider with published, protocol-specific efficacy data, including sleep results.
- You want both sublingual and subcutaneous administration options.
- You want a defined treatment framework with provider oversight, guide coaching, integration circles, and app-based support.
- You want treatment that is around 60 percent more affordable per session than IV ketamine clinics.
Another at-home provider may be right for you if:
- You prefer a daily very-low-dose approach.
- You are looking for a different pricing structure or program format.
- You have specific preferences about treatment cadence that align with another provider's offering.
Mindbloom treats clients with qualifying diagnoses of anxiety, depression, or PTSD. Sleep improvements occur in the context of treating those conditions, not as a standalone insomnia treatment. Eligibility is determined by a licensed physician during the medical evaluation.
Important Safety Information
Ketamine is not FDA-approved for PTSD, depression, or anxiety. Common side effects include dissociation, increased blood pressure, nausea, dizziness, and cognitive impairment. Ketamine has abuse potential and is not appropriate for patients with uncontrolled hypertension, psychotic disorders, or substance use disorders. Do not drive or operate machinery until the day after treatment. Individual results may vary. Full safety information: www.mindbloom.com/safety-information
Off-Label Use Disclosure
Ketamine is FDA-approved only as an anesthetic. Use for mental health conditions represents off-label prescribing by licensed clinicians based on clinical judgment. Schedule III Controlled Substance - DEA regulations apply.
Frequently asked questions
Is at-home ketamine therapy or in-clinic ketamine therapy safer?
As described in the safety protocols section above, at-home safety depends on care protocols, screening, and oversight rather than the treatment setting itself. Mindbloom's published data shows serious adverse events in fewer than 0.1 percent of sessions, reinforcing that supervised at-home protocols can maintain strong safety profiles.
Which at-home ketamine option is more affordable?
Mindbloom is roughly 60 percent more affordable per session than traditional IV ketamine clinics. While exact pricing varies among at-home providers, Mindbloom's per-session cost includes full provider consults, one-on-one guide coaching, and unlimited group integration support.
Do at-home ketamine providers publish outcomes on their own protocols?
Mindbloom has produced two peer-reviewed studies and additional preprints on its own specific treatment protocol. Most other at-home ketamine providers have not published protocol-specific data regarding their efficacy or safety.
Can I switch at-home ketamine providers if I start elsewhere?
Clients can transition between different at-home ketamine providers if they feel another care model better suits their needs. A new medical evaluation, similar to the initial screening described above, is required with the new provider.
Can I use HSA or FSA funds for at-home ketamine therapy?
At-home ketamine therapy programs through Mindbloom are eligible for HSA and FSA funds. Clients should verify specific coverage details and requirements directly with their plan administrator.
How long does a typical at-home ketamine session last?
Most guided at-home ketamine sessions last between 60 and 90 minutes. As noted above, a peer treatment monitor must be present for the entire session.
What happens during the post-session period?
The post-session period is a natural transition back to baseline where clients often reflect on their experience. Most people prefer to rest afterward, and you must avoid driving or operating machinery until after a full night of sleep.
Mindbloom Treatment
See what might be possible with clinician-guided, at-home ketamine therapy. New client programs start at $165 per session.
Authors
.jpg)
